Anakinra for Tocilizumab-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES) with Normal IL-1β Levels: A Case Report - Top-Institutions - MDSpire

Anakinra for Tocilizumab-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES) with Normal IL-1β Levels: A Case Report

  • By

  • Zhang, Lijun

  • Li, Deyuan

  • Wang, Jianjun

  • Wang, Xiao

  • Zhao, Wanling

  • Lu, Guoyan

  • June 1, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    NYU Langone Health
    NYU Langone Health

    New York, New York

    Key Differentiators

    • Neurology
    • Epilepsy

  • #2

    Yale University – Yale New Haven Hospital
    Yale University – Yale New Haven Hospital

    New Haven, Connecticut

    Key Differentiators

    • Neurology
    • Epilepsy

  • #3

    National Institutes of Health
    National Institutes of Health

    Bethesda, Maryland

    Key Differentiators

    • Neurology
    • Immunology

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Neurology
    • Epilepsy

  • #5

    Hebei Children’s Hospital
    Hebei Children’s Hospital

    Shijiazhuang, Hebei

    Key Differentiators

    • Pediatrics
    • Neurology

Original Source(s)

Anakinra for Tocilizumab-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES) with Normal IL-1β Levels: A Case Report

  • by Zhang, Lijun , Li, Deyuan , Wang, Jianjun , Wang, Xiao , Zhao, Wanling , Lu, Guoyan

  • June 1, 2026

Related Content

Correction: Analysis of treatment outcome variations in infantile epileptic spasms syndrome

Efficacy and Safety of Perampanel as the First Medication for Children with Newly Diagnosed Epilepsy: A Real-World Single-Center Prospective Observational Study

Optimizing EEG Channel and Frequency Band Selection for Enhanced Classification of Epileptic Seizures Through Multi-Objective Techniques